Use of gene NcSAG4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis

Details for Australian Patent Application No. 2004294741 (hide)

Owner Universidad Complutense de Madrid

Inventors Fernandez Garcia, Aurora; Ortega Mora, Luis Miguel

Agent Callinan

Pub. Number AU-B-2004294741

PCT Pub. Number WO2005/053505

Priority P200302869 04.12.03 ES

Filing date 26 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 6 October 2011

International Classifications

C07K 14/44 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

C12N 15/30 (2006.01) Mutation or genetic engineering - Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/053505 Priority application(s): WO2005/053505

6 October 2011 Application Accepted

  Published as AU-B-2004294741

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294757-Hand-held pipette for taking a liquid sample without temperature drift

2004294732-Streptococcus phocae vaccine